Immutep Limited - ADR Live Stock Price Today, Share Analysis and Chart

Name: Immutep Limited - ADR: Is Infosys Ltd. worth buying?
Item: Immutep Limited - ADR
Rating: 0.90991675
Author: Trendlyne DVM scores

about

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stim...

1.72 0.07 (4.24%)

36.76% Fall from 52W High

121.7K

XNAS Volume

XNAS 08 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

6.7 / 100

Technically Bearish

29.7 / 100

No estimates available

Immutep ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..